Shirai A, Catanzaro P J, Eisenberg G H, Osterman J V
Infect Immun. 1977 Nov;18(2):324-9. doi: 10.1128/iai.18.2.324-329.1977.
The effect of chloramphenicol treatment on the development of immunity to scrub typhus in mice was studied. Chemotherapy was administered either shortly before infection and for 14 days thereafter (group I), or from 7 to 21 days postinfection (group II). Although the full course of either regimen resulted in complete protection of the mice against subsequent challenge with the homologous strain of Rickettsia tsutsugamushi, initiation of chemotherapy at 7 days postinfection resulted in more rapid development of immunity against both the original infection and subsequent challenge. In both treatment groups, a 1- to 2- day hiatus was observed between immunity to challenge in the treated animal and the ability to transfer this immunity to syngeneic recipients with lymphocyte-enriched spleen cells. Similarly, complement-fixing antibodies were not detectable until shortly after the animals were able to resist challenge. These data supported the conclusion that the rickettsiostatic effect of chloramphenicol allows the infected animal time to mount an effective immune response and, further, that initiation of chemotherapy early in the infection may delay development of this response.
研究了氯霉素治疗对小鼠恙虫病免疫发展的影响。化疗在感染前不久给药,并在其后持续14天(第一组),或在感染后7至21天给药(第二组)。尽管两种方案的整个疗程都能使小鼠完全免受恙虫病立克次体同源菌株的后续攻击,但在感染后7天开始化疗会使针对原始感染和后续攻击的免疫发展更快。在两个治疗组中,观察到经治疗的动物对攻击的免疫与用富含淋巴细胞的脾细胞将这种免疫转移给同基因受体的能力之间有1至2天的间隔。同样,直到动物能够抵抗攻击后不久才能检测到补体结合抗体。这些数据支持了以下结论:氯霉素的立克次体抑制作用使受感染动物有时间产生有效的免疫反应,此外,在感染早期开始化疗可能会延迟这种反应的发展。